18th Annual NATA Symposium

17th Annual NATA Symposium, Prague 2015The 18th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis will take place at the Firenze Fiera Congress & Exhibition Center in Florence, Italy, on April 20-21, 2017.

The deadline for abstract submission is December 19, 2016.

The first announcement can be downloaded here in PDF format and here in Powerpoint format.

More information will be posted on Nataonline shortly.

Follow NATA on LinkedIn and Twitter

Join NATA's group on LinkedIn and follow NATA on Twitter (@NATAforum) to receive the latest news on patient blood management, haemostasis and thrombosis, and to participate in discussions with colleagues in the field.
LinkedIn Group / Twitter

Slide Presentations from the 16th Annual NATA Symposium, Prague, 2015

We are pleased to provide NATA members with PDF versions of presentations delivered at past NATA symposia. These presentations are made available for NATA members with permission from the authors and may have been modified to remove unpublished or copyrighted material.

To access presentations from the 16th Annual NATA Symposium, which was held in Prague on April 16-17, 2015, please log-in and go to the "Members' Area" section or click on the link below.
Slide Presentations from the 16th Annual NATA Symposium

News

AAGBI guidelines: the use of blood components and their alternatives 2016

This consensus document, published in the July issue of Anaesthesia, was produced by members of a Working Party established by the Association of Anaesthetists of Great Britain and Ireland (AAGBI). The document has been reviewed and endorsed by the Royal College of Anaesthetists and NATA.

The authors emphasize the importance of a transfusion practice based on current, scientific, evidence-based knowledge, and note that a multidisciplinary approach that aims to benefit patients by the reduction in inappropriate transfusions is paramount.
Read more on this

From the Literature

Aug 25, 2016

Published: Jul 2016

Lucas DJ, Ejaz A, Spolverato G, et al.

Packed red blood cell transfusion after surgery: are we "overtranfusing" our patients?
Am J Surg 2016;212:1-9.

#

NATA REVIEW:
Using data from a prospective blood management intelligence portal, Lucas and co-authors performed an analysis...
REVIEW by:
T. Frietsch

Published: Jul 2016

Stevens LM, Noiseux N, Prieto I, Hardy JF

Major transfusions remain frequent despite the generalized use of tranexamic acid: an audit of 3322 patients undergoing cardiac surgery.
Transfusion 2016;56:1857-1865.

#

NATA REVIEW:
With the improvements made in non-invasive cardiac therapies (e.g. percutaneous transluminal coronary angioplasty)...
REVIEW by:
D. Faraoni

Published: Jul 2016

Jankowska EA, Tkaczyszyn M, Suchocki T, et al.

Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
Eur J Heart Fail 2016;18:786-795.

#

NATA REVIEW:
Iron deficiency has been observed in a large proportion of patients with chronic heart failure. Most importantly,...
REVIEW by:
D. Faraoni

Published: Jul 2016

Marx G, Schindler AW, Mosch C, et al.

Intravascular volume therapy in adults: Guidelines from the Association of the Scientific Medical Societies in Germany.
Eur J Anaesthesiol 2016;33:488-521.

#

NATA REVIEW:
These guidelines on volume therapy should be considered in the bundle concept of patient blood management (PBM)...
REVIEW by:
S. Kozek-Langenecker

Published: Jul 2016

Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM

The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial.
Ann Surg 2016;264:41-46.

#

NATA REVIEW:
In this study, patients with confirmed iron-deficiency anaemia (IDA) scheduled for major abdominal surgery (mostly...
REVIEW by:
M. Muñoz

Published: Jul 2016

Rahe-Meyer N, Levy JH, Mazer CD, et al.

Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy.
Br J Anaesth 2016;117:41-51.

#

NATA REVIEW:
In view of the low levels of fibrinogen in various clinical circumstances associated with haemorrhage, replacement...
REVIEW by:
M. Levi